Ebola & Marburg

Colorized transmission electron micrograph of Ebola virus particles (blue) found both as extracellular particles and budding particles from chronically-infected African green monkey kidney cells (brown).

Credit: NIAID

NIAID is conducting and supporting research to find new and improved ways to diagnose, treat, and prevent Ebola and Marburg infections. Through the information offered here, the Ebola and Marburg scientific community can learn about NIAID funding opportunities, programs, and networks to further research and encourage collaboration. This section also provides information on resources provided by NIAID to advance product development.   


NIAID is always accepting researcher-initiated applications. Connect with NIAID program officers about potential or related funding for Ebola virus and Marburg virus research.

Program Officers

  • Dr. Walla Dempsey, Program Officer, Clinical Research, Virology Branch
  • Dr. Patricia Repik, Program Officer, Alphaviruses, Arenaviruses, Bunyaviruses and Filoviruses, Virology Branch
  • Dr. Sara Woodson, Product Development Manager, Virology Branch
  • Dr. Michael Schaefer, Chief, Translational Centers of Excellence and Research Coordination Section, Office of Biodefense Research Resources and Translational Research

Resources for Researchers

NIAID offers resources to advance science from basic research through advanced clinical evaluation, with the goal of developing new and improved products such as diagnostics, vaccines and therapeutics. Resources to support basic research include the BEI Resources Repository, which provides organisms and reagents to the scientific community, while clinical research resources include the Vaccine and Treatment Evaluation Units., which conduct Phase I, II, and IV clinical trials across the United States.

Available preclinical services programs include:

See a full list of resources for Ebola & Marburg researchers


The NIAID-funded Centers of Excellence for Translational Research program is funding innovative research to develop novel therapeutics and vaccines against Ebola and Marburg viruses. Filovirus research is also supported through the National Biocontainment Research Facilities.

See a full list of Ebola & Marburg networks funded by NIAID
Content last reviewed on